ask the expert: sabcs highlights
Published 1 year ago • 1.8K plays • Length 56:30Download video MP4
Download video MP3
Similar videos
-
6:23
sabcs 2022: new breast cancer treatments
-
3:24
cdk4/6 for hr early breast cancer: monarche results
-
7:02
breast cancer recurrence risk based on ctdna
-
6:24
cdk4/6 inhibitors: can they be used for tnbc or her2 breast cancer?
-
3:31
genetic markers and risk of second breast cancer based
-
20:17
sabcs snippets: after asco 2024
-
18:38
breast cancer esmo 2024 highlights: key studies discussed natalee, keynote 522, destiny-breast12
-
5:32
sabcs snippets: the us fda approval of ribociclib
-
2:31
what is her2 low in breast cancer?
-
3:47
breast cancer: whether to pause hormone therapy for pregnancy
-
2:48
early breast cancer treatment: tamoxifen dosage options
-
1:53
can vaginal estrogen be an issue with endocrine therapy?
-
22:51
sabcs 2023 breast cancer highlights – natalee, monarch-3, inavo120, tropion-breast01
-
13:51
esmo 2023 breast cancer highlights – keynote 756, tropion-breast01, keynote 52 | onc brothers
-
49:34
ask the expert: updates from the 2023 san antonio breast cancer symposium (sabcs)
-
1:51:16
dr. bora lim | challenging types of breast cancer | sabcs 2022 | education session
-
5:55
sabcs snippets: magnetic resonance imaging and a 12-gene expression assay
-
3:07
highlights from sabcs 2021: t-dxd, keynote-355, pada-1 & emerald
-
57:53
sabcs clinical case discussions
-
14:35
sabcs 2023 her2 breast cancer highlights – aphinity sub-analysis, katherine update, her2climb-02
-
17:14
sabcs 2023 breast cancer highlights – nsabp b-51, idea update, icaro, keynote 522 update
-
1:59
ask the expert: breast health